Logo image of OPHC

OPTIMUMBANK HOLDINGS INC (OPHC) Stock Fundamental Analysis

USA - NYSEARCA:OPHC - US68401P4037 - Common Stock

4.16 USD
-0.03 (-0.72%)
Last: 9/16/2025, 8:04:03 PM
Fundamental Rating

4

Overall OPHC gets a fundamental rating of 4 out of 10. We evaluated OPHC against 392 industry peers in the Banks industry. OPHC has only an average score on both its financial health and profitability. OPHC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year OPHC was profitable.
OPHC had a positive operating cash flow in the past year.
Of the past 5 years OPHC 4 years were profitable.
OPHC had a positive operating cash flow in 4 of the past 5 years.
OPHC Yearly Net Income VS EBIT VS OCF VS FCFOPHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

With an excellent Return On Assets value of 1.50%, OPHC belongs to the best of the industry, outperforming 89.03% of the companies in the same industry.
OPHC has a Return On Equity of 13.54%. This is amongst the best in the industry. OPHC outperforms 89.03% of its industry peers.
Industry RankSector Rank
ROA 1.5%
ROE 13.54%
ROIC N/A
ROA(3y)0.96%
ROA(5y)0.87%
ROE(3y)9.37%
ROE(5y)8.02%
ROIC(3y)N/A
ROIC(5y)N/A
OPHC Yearly ROA, ROE, ROICOPHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

OPHC has a better Profit Margin (35.67%) than 92.86% of its industry peers.
OPHC's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for OPHC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 35.67%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-16.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OPHC Yearly Profit, Operating, Gross MarginsOPHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

OPHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
OPHC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for OPHC has been increased compared to 5 years ago.
There is no outstanding debt for OPHC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OPHC Yearly Shares OutstandingOPHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
OPHC Yearly Total Debt VS Total AssetsOPHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

OPHC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC22.49%
OPHC Yearly LT Debt VS Equity VS FCFOPHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
OPHC Yearly Current Assets VS Current LiabilitesOPHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

4

3. Growth

3.1 Past

OPHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.15%, which is quite impressive.
Measured over the past years, OPHC shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.10% on average per year.
The Revenue has grown by 35.00% in the past year. This is a very strong growth!
The Revenue has been growing by 64.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)30.15%
EPS 3Y-6.1%
EPS 5YN/A
EPS Q2Q%1.61%
Revenue 1Y (TTM)35%
Revenue growth 3Y52.11%
Revenue growth 5Y64.04%
Sales Q2Q%18.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y1.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OPHC Yearly Revenue VS EstimatesOPHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
OPHC Yearly EPS VS EstimatesOPHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 0.2 0.4 0.6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

OPHC is valuated cheaply with a Price/Earnings ratio of 3.13.
Based on the Price/Earnings ratio, OPHC is valued cheaper than 98.72% of the companies in the same industry.
OPHC is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
OPHC is valuated cheaply with a Price/Forward Earnings ratio of 6.69.
Based on the Price/Forward Earnings ratio, OPHC is valued cheaply inside the industry as 92.35% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of OPHC to the average of the S&P500 Index (22.71), we can say OPHC is valued rather cheaply.
Industry RankSector Rank
PE 3.13
Fwd PE 6.69
OPHC Price Earnings VS Forward Price EarningsOPHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, OPHC is valued cheaper than 96.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.22
EV/EBITDA N/A
OPHC Per share dataOPHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates OPHC does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)1.88
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OPHC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPTIMUMBANK HOLDINGS INC

NYSEARCA:OPHC (9/16/2025, 8:04:03 PM)

4.16

-0.03 (-0.72%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners14.46%
Inst Owner Change13.54%
Ins Owners13.91%
Ins Owner Change0%
Market Cap48.88M
Analysts43.33
Price Target5.1 (22.6%)
Short Float %0.08%
Short Ratio0.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)93.19%
Min EPS beat(2)84.54%
Max EPS beat(2)101.85%
EPS beat(4)4
Avg EPS beat(4)101.17%
Min EPS beat(4)84.54%
Max EPS beat(4)122.22%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-15.28%
EPS NY rev (3m)-15.28%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.13
Fwd PE 6.69
P/S 1.19
P/FCF 3.22
P/OCF 3.02
P/B 0.45
P/tB 0.45
EV/EBITDA N/A
EPS(TTM)1.33
EY31.97%
EPS(NY)0.62
Fwd EY14.96%
FCF(TTM)1.29
FCFY31.06%
OCF(TTM)1.38
OCFY33.13%
SpS3.49
BVpS9.19
TBVpS9.19
PEG (NY)1.88
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.5%
ROE 13.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 35.67%
GM N/A
FCFM 37.05%
ROA(3y)0.96%
ROA(5y)0.87%
ROE(3y)9.37%
ROE(5y)8.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-16.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 295.91%
Cap/Sales 2.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 103.87%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC22.49%
ROIC/WACCN/A
Cap/Depr(3y)253.88%
Cap/Depr(5y)210.74%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.77%
Profit Quality(3y)153.34%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.15%
EPS 3Y-6.1%
EPS 5YN/A
EPS Q2Q%1.61%
EPS Next Y1.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35%
Revenue growth 3Y52.11%
Revenue growth 5Y64.04%
Sales Q2Q%18.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y84.5%
FCF growth 3Y62.92%
FCF growth 5YN/A
OCF growth 1Y85.31%
OCF growth 3Y60.7%
OCF growth 5YN/A